A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries

Autor: Humbert, Maria Victoria, Opurum, Precious Chinonyerem, Brendish, Nathan J, Poole, Stephen, He, Peijun, Katis, Ioannis, Quaye, Jerry, Bediako, Yaw, Duriez, Patrick Jacques, Eason, Robert W, Sones, Collin, Quaye, Osbourne, Awandare, Gordon A, Christodoulides, Myron, Clark, Tristan W, Quashie, Peter K, McCormick, Christopher J
Zdroj: In Journal of Infection January 2022 84(1):48-55
Databáze: ScienceDirect
Externí odkaz: